Bio-Rad is a world leader in providing a broad range of innovative tools and services to the clinical diagnostics and life science research markets. The company serves more than 70,000 research and industry customers worldwide through a network of more than 30 wholly owned subsidiary offices.
No single public or private company has a comparable mix of products which serve the same markets. Collectively, the peer group reflects products and markets similar to Bio-Rad's participation in life science research products and clinical diagnostics markets. The peer group consists of the following public companies: Amersham, Applied Biosystems, Invitrogen, Qiagen, Affymetrix, Beckman Coulter, Roche, Abbott, Beckton Dickinson and Johnson & Johnson.